CHRS
Price
$1.06
Change
-$0.24 (-18.46%)
Updated
Sep 16, 03:08 PM (EDT)
49 days until earnings call
EWTX
Price
$18.83
Change
+$1.26 (+7.17%)
Updated
Sep 13 closing price
52 days until earnings call
Ad is loading...

CHRS vs EWTX

Header iconCHRS vs EWTX Comparison
Open Charts CHRS vs EWTXBanner chart's image
Coherus BioSciences
Price$1.06
Change-$0.24 (-18.46%)
Volume$20.4K
CapitalizationN/A
Edgewise Therapeutics
Price$18.83
Change+$1.26 (+7.17%)
Volume$739.79K
CapitalizationN/A
View a ticker or compare two or three
CHRS vs EWTX Comparison Chart
Loading...
CHRS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
EWTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CHRS vs. EWTX commentary
Sep 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHRS is a Sell and EWTX is a Sell.

COMPARISON
Comparison
Sep 16, 2024
Stock price -- (CHRS: $1.30 vs. EWTX: $18.83)
Brand notoriety: CHRS and EWTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CHRS: 66% vs. EWTX: 92%
Market capitalization -- CHRS: $149.77M vs. EWTX: $1.77B
CHRS [@Biotechnology] is valued at $149.77M. EWTX’s [@Biotechnology] market capitalization is $1.77B. The market cap for tickers in the [@Biotechnology] industry ranges from $606.91B to $0. The average market capitalization across the [@Biotechnology] industry is $3.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CHRS’s FA Score shows that 0 FA rating(s) are green whileEWTX’s FA Score has 1 green FA rating(s).

  • CHRS’s FA Score: 0 green, 5 red.
  • EWTX’s FA Score: 1 green, 4 red.
According to our system of comparison, EWTX is a better buy in the long-term than CHRS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CHRS’s TA Score shows that 3 TA indicator(s) are bullish while EWTX’s TA Score has 3 bullish TA indicator(s).

  • CHRS’s TA Score: 3 bullish, 3 bearish.
  • EWTX’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, CHRS is a better buy in the short-term than EWTX.

Price Growth

CHRS (@Biotechnology) experienced а +4.84% price change this week, while EWTX (@Biotechnology) price change was +7.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.08%. For the same industry, the average monthly price growth was +4.25%, and the average quarterly price growth was -1.72%.

Reported Earning Dates

CHRS is expected to report earnings on Nov 04, 2024.

EWTX is expected to report earnings on Nov 07, 2024.

Industries' Descriptions

@Biotechnology (+2.08% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EWTX($1.77B) has a higher market cap than CHRS($150M). EWTX YTD gains are higher at: 72.121 vs. CHRS (-60.961). CHRS has higher annual earnings (EBITDA): 12.3M vs. EWTX (-134.09M). EWTX has more cash in the bank: 512M vs. CHRS (159M). EWTX has less debt than CHRS: EWTX (4.99M) vs CHRS (270M). CHRS has higher revenues than EWTX: CHRS (308M) vs EWTX (0).
CHRSEWTXCHRS / EWTX
Capitalization150M1.77B8%
EBITDA12.3M-134.09M-9%
Gain YTD-60.96172.121-85%
P/E RatioN/AN/A-
Revenue308M0-
Total Cash159M512M31%
Total Debt270M4.99M5,416%
FUNDAMENTALS RATINGS
CHRS: Fundamental Ratings
CHRS
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
63
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CHRSEWTX
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
78%
Momentum
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
84%
MACD
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 7 days ago
73%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
86%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
84%
View a ticker or compare two or three
Ad is loading...
CHRS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
EWTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TORIX17.420.18
+1.04%
Tortoise Energy Infrastructure TR Ins
JABAX47.780.23
+0.48%
Janus Henderson Balanced T
BIIEX22.530.03
+0.13%
Brandes International Equity I
IAFMX17.190.02
+0.12%
F/m Investments Large Cap Focused Inv
HNCYX17.890.01
+0.06%
Hartford International Growth Y

CHRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CHRS has been loosely correlated with AURA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CHRS jumps, then AURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHRS
1D Price
Change %
CHRS100%
+0.78%
AURA - CHRS
51%
Loosely correlated
+2.86%
ABCL - CHRS
46%
Loosely correlated
+2.61%
MDXG - CHRS
44%
Loosely correlated
+1.14%
DNLI - CHRS
43%
Loosely correlated
+10.05%
PRME - CHRS
42%
Loosely correlated
+0.99%
More

EWTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, EWTX has been loosely correlated with CYTK. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if EWTX jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EWTX
1D Price
Change %
EWTX100%
+7.17%
CYTK - EWTX
41%
Loosely correlated
+3.37%
TNYA - EWTX
40%
Loosely correlated
-2.91%
CHRS - EWTX
36%
Loosely correlated
+0.78%
ATAI - EWTX
35%
Loosely correlated
+5.69%
ARDX - EWTX
35%
Loosely correlated
+1.45%
More